Home Aldehydes 886615-30-1
886615-30-1,MFCD11111905
Catalog No.:AA00367M

886615-30-1 | 3-Bromo-6-chloro-2-fluorobenzaldehyde

Pack Size
Purity
Availability
Price(USD)
Quantity
  
250mg
98%
in stock  
$22.00   $15.00
- +
1g
95%
in stock  
$41.00   $29.00
- +
5g
95%
in stock  
$185.00   $130.00
- +
100g
98%
in stock  
$1,336.00   $935.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA00367M
Chemical Name:
3-Bromo-6-chloro-2-fluorobenzaldehyde
CAS Number:
886615-30-1
Molecular Formula:
C7H3BrClFO
Molecular Weight:
237.4535
MDL Number:
MFCD11111905
SMILES:
O=Cc1c(Cl)ccc(c1F)Br
Properties
Properties
 
Form:
Solid  
Storage:
Room Temperature;  

Computed Properties
 
Complexity:
155  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
11  
Hydrogen Bond Acceptor Count:
2  
Rotatable Bond Count:
1  
XLogP3:
2.8  

Downstream Synthesis Route

[1]CurrentPatentAssignee:ELILILLY&CO-WO2006/49952,2006,A1Locationinpatent:Page/Pagecolumn53

[1]CurrentPatentAssignee:ELILILLY&CO-WO2006/49952,2006,A1Locationinpatent:Page/Pagecolumn53

[2]CurrentPatentAssignee:CORTEVAINC-US2007/179060,2007,A1Locationinpatent:Page/Pagecolumn10

886615-30-1   
1-bromo-4-chloro-2-fluoro-3-difluoromethylbenzene 

[1]CurrentPatentAssignee:CORTEVAINC-WO2007/82076,2007,A1Locationinpatent:Page/Pagecolumn28-29

[2]CurrentPatentAssignee:CORTEVAINC-US2007/179060,2007,A1Locationinpatent:Page/Pagecolumn9

886615-30-1   
3-bromo-6-chloro-2-fluorobenzonitrile 

[1]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2020/157692,2020,A1Locationinpatent:Page/Pagecolumn10;11

[2]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2020/254985,2020,A1Locationinpatent:Page/Pagecolumn11-12

[3]CurrentPatentAssignee:CORTEVAINC-WO2007/82076,2007,A1Locationinpatent:Page/Pagecolumn32

[4]CurrentPatentAssignee:CORTEVAINC-US2007/179060,2007,A1Locationinpatent:Page/Pagecolumn12

[5]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2018/203235,2018,A1Locationinpatent:Page/Pagecolumn115-116

[6]CurrentPatentAssignee:GILEADSCIENCESINC-WO2019/161280,2019,A1Locationinpatent:Paragraph00612

[7]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2019/198024,2019,A1Locationinpatent:Page/Pagecolumn45

[8]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2020/95176,2020,A1Locationinpatent:Page/Pagecolumn18

[9]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2020/84492,2020,A1Locationinpatent:Page/Pagecolumn29-30

[10]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2020/84480,2020,A1Locationinpatent:Page/Pagecolumn18

[11]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2020/89778,2020,A1Locationinpatent:Page/Pagecolumn12

[12]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2020/84491,2020,A1Locationinpatent:Page/Pagecolumn23-24

[13]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2020/222108,2020,A1Locationinpatent:Page/Pagecolumn12

[1]CurrentPatentAssignee:CANCERTHERAPEUTICSCRCPTYLTD-WO2019/219820,2019,A1Locationinpatent:Page/Pagecolumn111

[2]CurrentPatentAssignee:CORTEVAINC-WO2007/82076,2007,A1Locationinpatent:Page/Pagecolumn28

[3]CurrentPatentAssignee:CORTEVAINC-US2007/179060,2007,A1Locationinpatent:Page/Pagecolumn8-9

[4]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2018/203235,2018,A1Locationinpatent:Page/Pagecolumn115

[5]CurrentPatentAssignee:GILEADSCIENCESINC-WO2019/161280,2019,A1Locationinpatent:Paragraph00611

[6]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2019/198024,2019,A1Locationinpatent:Page/Pagecolumn44-45

[7]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2020/95176,2020,A1Locationinpatent:Page/Pagecolumn17-18

[8]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2020/84492,2020,A1Locationinpatent:Page/Pagecolumn29

[9]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2020/84480,2020,A1Locationinpatent:Page/Pagecolumn18

[10]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2020/89778,2020,A1Locationinpatent:Page/Pagecolumn11-12

[11]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2020/84491,2020,A1Locationinpatent:Page/Pagecolumn23

[12]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2020/222108,2020,A1Locationinpatent:Page/Pagecolumn11-12

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:886615-30-1 Molecular Formula|886615-30-1 MDL|886615-30-1 SMILES|886615-30-1 3-Bromo-6-chloro-2-fluorobenzaldehyde